Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-05-09
2011-12-13
Haddad, Maher (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C424S184100, C530S325000, C530S350000
Reexamination Certificate
active
08076087
ABSTRACT:
Isolated polynucleotides encoding novel galectin-8 variants polypeptides are provided. Also provided are methods and kits using same for diagnosing prognosing and treating rheumatoid arthritis (RA) and other joint/chronic inflammatory diseases.
REFERENCES:
patent: 3687808 (1972-08-01), Merigan, Jr. et al.
patent: 4036945 (1977-07-01), Haber
patent: 4331647 (1982-05-01), Goldenberg
patent: 4469863 (1984-09-01), Ts'o et al.
patent: 4476301 (1984-10-01), Imbach et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4873316 (1989-10-01), Meade et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5023243 (1991-06-01), Tullis
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5166315 (1992-11-01), Summerton et al.
patent: 5177196 (1993-01-01), Meyer, Jr. et al.
patent: 5185444 (1993-02-01), Summerton et al.
patent: 5188897 (1993-02-01), Suhadolnik et al.
patent: 5214134 (1993-05-01), Weis et al.
patent: 5216141 (1993-06-01), Benner
patent: 5235033 (1993-08-01), Summerton et al.
patent: 5264423 (1993-11-01), Cohen et al.
patent: 5264562 (1993-11-01), Matteucci
patent: 5264564 (1993-11-01), Matteucci
patent: 5272057 (1993-12-01), Smulson et al.
patent: 5276019 (1994-01-01), Cohen et al.
patent: 5278302 (1994-01-01), Caruthers et al.
patent: 5286717 (1994-02-01), Cohen et al.
patent: 5321131 (1994-06-01), Agrawal et al.
patent: 5399676 (1995-03-01), Froehler
patent: 5405938 (1995-04-01), Summerton et al.
patent: 5405939 (1995-04-01), Suhadolnik et al.
patent: 5434257 (1995-07-01), Matteucci et al.
patent: 5453496 (1995-09-01), Caruthers et al.
patent: 5455233 (1995-10-01), Spielvogel et al.
patent: 5464764 (1995-11-01), Capecchi et al.
patent: 5466677 (1995-11-01), Baxter et al.
patent: 5470967 (1995-11-01), Huie et al.
patent: 5476925 (1995-12-01), Letsinger et al.
patent: 5487992 (1996-01-01), Capecchi et al.
patent: 5489677 (1996-02-01), Sanghvi et al.
patent: 5519126 (1996-05-01), Hecht
patent: 5536821 (1996-07-01), Agrawal et al.
patent: 5539082 (1996-07-01), Nielsen et al.
patent: 5541306 (1996-07-01), Agrawal et al.
patent: 5541307 (1996-07-01), Cook et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5550111 (1996-08-01), Suhadolnik et al.
patent: 5561225 (1996-10-01), Maddry et al.
patent: 5563253 (1996-10-01), Agrawal et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5571799 (1996-11-01), Tkachuk et al.
patent: 5587361 (1996-12-01), Cook et al.
patent: 5596086 (1997-01-01), Matteucci et al.
patent: 5602240 (1997-02-01), De Mesmaeker et al.
patent: 5608046 (1997-03-01), Cook et al.
patent: 5610289 (1997-03-01), Cook et al.
patent: 5618704 (1997-04-01), Sanghvi et al.
patent: 5623070 (1997-04-01), Cook et al.
patent: 5625050 (1997-04-01), Beaton et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633360 (1997-05-01), Bischofberger et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5663312 (1997-09-01), Chaturvedula
patent: 5677437 (1997-10-01), Teng et al.
patent: 5677439 (1997-10-01), Weis et al.
patent: 5714331 (1998-02-01), Buchardt et al.
patent: 5719262 (1998-02-01), Buchardt et al.
patent: 5869289 (1999-02-01), Hawkins et al.
patent: 5908761 (1999-06-01), Zick
patent: 5932447 (1999-08-01), Siegall
patent: 6027916 (2000-02-01), Ni et al.
patent: 6281333 (2001-08-01), Hawkins et al.
patent: 6303374 (2001-10-01), Zhang et al.
patent: 6468768 (2002-10-01), Ni et al.
patent: 6759192 (2004-07-01), Blumenfeld et al.
patent: 7176181 (2007-02-01), Zick et al.
patent: 2003/0050266 (2003-03-01), Fisher et al.
patent: 2005/0215464 (2005-09-01), Melnik et al.
patent: 2006/0009378 (2006-01-01), Golan et al.
patent: 2007/0160602 (2007-07-01), Zick et al.
patent: 2008/0139460 (2008-06-01), Melnik et al.
patent: 0264166 (1996-06-01), None
patent: 1767634 (2007-03-01), None
patent: 2003-246749 (2003-09-01), None
patent: WO 95/15175 (1995-06-01), None
patent: WO 98/15624 (1998-04-01), None
patent: WO 99/12041 (1999-03-01), None
patent: WO 99/64590 (1999-12-01), None
patent: WO 02/089831 (2002-11-01), None
patent: WO 03/072606 (2003-09-01), None
patent: WO 2004/043332 (2004-05-01), None
patent: WO 2005/016962 (2005-02-01), None
patent: WO 2006/000548 (2006-01-01), None
patent: WO 2006/120678 (2006-11-01), None
Official Action Dated Apr. 28, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/907,893.
Official Action Dated Nov. 6, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/505,769.
Official Action Dated Apr. 18, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/505,769.
Communication Pursuant to Article 94(3) EPC Dated Dec. 9, 2009 From the European Patent Office Re.: Application No. 03772618.9.
Communication Pursuant to Article 94(3) EPC Dated Nov. 27, 2009 From the European Patent Office Re.: Application No. 03743006.3.
Communication Pursuant to Article 96(2) EPC Dated Sep. 3, 2007 From the European Patent Office Re.: Application No. 03743006.3.
Office Action Dated Mar. 4, 2010 From the Israel Patent Office Re.: Application No. 187244 and Its Translation Into English.
Office Action Dated Mar. 8, 2010 From the Israeli Patent Office Re.: Application No. 195447 and Its Translation Into English.
Office Action Dated Mar. 8, 2010 From the Israeli Patent Office Re.: Application No. 195448 and Its Translation Into English.
Office Action Dated Jul. 21, 2008 From the Israeli Patent Office Re.: Application No. 168519.
Official Action Dated Jul. 13, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/907,893.
Official Action Dated Sep. 17, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/907,893.
Official Action Dated Apr. 18, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/505,769.
Response Dated Mar. 17, 2010 to Official Action of Sep. 17, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/907,893.
Bidon et al. “Galectin-8: A Complex Sub-Family of Galectins (Review)”, International Journal of Molecular Medicine, 8(3): 245-250, 2001. Abstract.
Germain et al. “Cleavage of Automodified Poly(ADP-Ribose) Polymerase During Apoptsis”, Journal of Biological Chemistry, 274(40): 28379-28384, 1999.
Gopalkrishnan et al. “Molecular Characterization of Prostate Carcinoma Tumor Antigen-1, PCTA-1, A Human Galectin-8 Related Gene”, Oncogene, 19: 4405-4416, 2000. Abstract.
Hadari et al. “Galectin-8 Binding to Integrins Inhibits Cell Adhesion and Induces Apoptosis”, Journal of Cell Science, XP002250560, 113(13): 2385-2397, 2000. Abstract. p. 2391, col. 2.
Hadari et al. “Galectin-8: On the Road From Structure to Function”, Trends in Glycoscience and Glycotechnology, 9(45): 103-112, 1997.
Katoh et al. “Galectin-9 Inhibits CD44-Hyaluronan Interaction and Suppresses a Murine Model of Allergic Asthma”, American Journal of Respiratory and Critical Medicine, 176(1): 27-35, Jul. 1, 2007.
Lazebnik “Cleavage of Poly(ADP-Ribose) Polymerase by a Proteinase With Properties Like ICE”, Nature, 371(6495): 346-347, 1994. Abstract.
Lesley et al. “CD44 and Its Interaction With Extracellular Matrix”, Advances in Immunology, 54: 271-335, 1993. Abstract.
Lesley et al. “Variant Cell Lines Selected for Alterations in the Function of the Hyaluronan Receptor CD44 Show Differences in Glycosylation”, Journal of Experimental Medicine, 182: 431-437, 1995.
Levy et al. “Galectin-8 Functions as a Matricellular Modulator of Cell Adhesion”, The Journal of Biological Chemistry, 276(33): 31285-31295, 2001.
Lio “Galectins: A New Family of Regulators of Inglammation”, Clinical Immunology, 97: 79-88, 2000.
Naor et al. “CD44: Structure, Function, and Asssociation With the Malignant Process”, Advances in Cancer Research, 71: 241-319, 1997. Abstract.
Screaton et al. “The Identification of a New Alternative Exon With Highly Restricted Tissue Expression in Transcripts Encoding the Mouse Pgp-1 (CD44) Homing Receptor”,
Caspi Dan
Golan Itshak
Melnik Lora
Haddad Maher
Medical Research Fund of Tel Aviv Souraskv Medical Center
Yeda Research And Development Co. Ltd.
Yissum-Research Development Company of the Hebrew University of
LandOfFree
Galectin sequences and compositions and methods utilizing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Galectin sequences and compositions and methods utilizing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galectin sequences and compositions and methods utilizing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4313601